Relationship of dermatomyositis and deep vein thrombosis: Case report
DOI:
https://doi.org/10.61182/rnavmed.v10n2a4Keywords:
Dermatomyositis, Deep vein thrombosis, Autoimmune diseasesAbstract
Dermatomyositis is an inflammatory myopathy of autoimmune etiology, characterized by symmetrical involvement of muscle groups, generally proximal. This condition can present progressive deterioration affecting the mobility of certain muscle groups, and can also present with other complications, such as vascular involvement, which predisposes to thrombus formation. We present the case of a 40-year-old patient admitted for progressive deterioration of strength in the lower limbs, who was diagnosed with dermatomyositis based on quadriceps muscle biopsy findings. Subsequently, he presented a deep vein thrombosis associated with the disease.
References
(1) Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet [Internet]. 2003 Sep 20 [cited 2024 Jul 7];362(9388):971–82. https://pubmed.ncbi.nlm.nih.gov/14511932/
(2) Bendewald MJ, Wetter DA, Li X, Davis MDP. Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis: A Population-Based Study in Olmsted County, Minnesota. Arch Dermatol [Internet]. 2010 Jan [cited 2024 Jul 7];146(1):26. https://doi.org/10.1001/archdermatol.2009.328
(3) Greenberg SA. Inflammatory Myopathies: Evaluation and Management. Semin Neurol. 2008 Apr;28(2):241–9. https://doi.org/10.1055/s-2008-1062267
(4) Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev. 2014;13(4–5):367–71. https://doi.org/10.1016/j.autrev.2014.01.022
(5) Nakashima R. Clinical significance of myositis-specific autoantibodies. Immunol Med [Internet]. 2018 Jul 3 [cited 2024 Jul 7];41(3):103–12. https://doi.org/10.1080/25785826.2018.1531188
(6) Zöller B, Li X, Sundquist J, Sundquist K. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis. 2012;2(3):171. https://pmc.ncbi.nlm.nih.gov/articles/PMC3427982/
(7) Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M de, et al. EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and their Major Subgroups. Ann Rheum Dis. 2017 Dec 1;76(12):1955. https://doi.org/10.1136/rmdopen-2017-000507
(8) Ashton C, Paramalingam S, Stevenson B, Brusch A, Needham M. Idiopathic inflammatory myopathies: a review. Intern Med J. 2021 Jun;51(6):845–52. https://doi.org/10.1111/imj.15358
(9) Baig S, Paik JJ. Inflammatory muscle disease e An update. 2020 [cited 2024 Jul 13]; 34(1):101484. https://doi.org/10.1016/j.berh.2019.101484
(10) Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis [Internet]. 2019 [cited 2024 Jul 13]; 78:1296–304. https://doi.org/10.1136/annrheumdis-2019-215213
Downloads
Published
Data Availability Statement
--
Issue
Section
License
Copyright (c) 2024 Ferney Samuel Contento-Anaya , Ricardo Andrés Donado-Botero, Mario Enrique Montoya-Jaramillo , Camilo Andrés Arango, Maria José Santana-Ruiz , Valentina Porto-Eljaiek , María Paula Chimbi-Bru, María de los Ángeles Díaz-Rosales, David Fernando Ortiz-Pérez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
